The global Retinal Imaging Devices market Growth Accelerated by Rise in Prevalence of Eye Diseases


 Retinal imaging devices are medical devices that are used to capture high-quality images of the retina. These devices help physicians examine the retina and diagnose retinal diseases in earlier stages. They capture images digitally with advanced software that enhances the visualization of retinal details.

The global Retinal Imaging Devices market is estimated to be valued at US$ 1,272.1 million in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The retinal imaging devices market is witnessing significant growth owing to the rise in prevalence of eye diseases such as diabetic retinopathy, age-related macular degeneration, and retinal detachment. According to the World Health Organization, the number of people with diabetic retinopathy is expected to increase from 126.6 million in 2030 to 191.0 million by 2045. Retinal imaging devices are increasingly being used in screening programs for early detection of such retinal diseases. Furthermore, technological advancements in retinal imaging systems allowing non-mydriatic imaging and wide-field visualization are augmenting their adoption. This is encouraging manufacturers to further develop handheld, portable, and inexpensive retinal imaging solutions.


Segment Analysis
The global retinal imaging devices market is segmented into fundus cameras,OCT scanners,and lensometers. Fundus cameras captured the largest share of more 35% in 2022. Fundus cameras allow ophthalmologists to take photos of the inside of the eye for diagnostic purposes. Its non-invasive nature and ability to capture high-resolution images make it the most commonly used retinal imaging device.

Key Takeaways
The global retinal imaging devices market is expected to witness high growth over the forecast period. The global Retinal Imaging Devices market is estimated to be valued at US$ 1,272.1 million in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030.

Regional analysis:
North America currently dominates the market accounting for over 30% share. High healthcare expenditures,increasing geriatric population and favourable reimbursement policies are some factors driving the regional market. Asia Pacific is expected emerge as the fastest growing region growing at a CAGR of over 12% during the forecast period. Rising cases of diabetes and improving access to diagnostic procedures are boosting the APAC retinal imaging devices market.

Key players:
Key players operating in the retinal imaging devices market are Topcon Corporation, Carl Zeiss Meditec AG, Optovue, Nidek Co. Ltd,CenterVue SpA,Escalon Medical Corp.,Ellex Medical Lasers Ltd.,Optomed, and Canon Inc. 

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure